Angeion And Mortara Partner To Produce MedGraphics Ultima™ CardiO2
Angeion Corporation (NASDAQ: ANGN) today announced that it is partnering with Milwaukee, Wis.-based Mortara Instrument, Inc., to produce the Ultima™ CardiO 2 metabolic stress testing system.
Mortara Instrument is a leader in non-invasive electrocardiography (ECG) products. The Ultima CardiO 2, part of Angeion’s MedGraphics product line, incorporates an integrated 12-lead ECG from Mortara Instrument to enhance testing capabilities, making the system a complete metabolic stress testing solution that provides true breath-by-breath analysis. This enables clinicians to quickly and efficiently measure key pulmonary, cardiopulmonary and nutritional functions.
“We first unveiled the Ultima CardiO 2 in 1993. By partnering with Mortara, we are able to enhance the system’s ECG element with the leading electrocardiography technology available today,” said Rodney A. Young, President and Chief Executive Officer of Angeion. “The latest Ultima CardiO 2 is a system that offers complete pulmonary function assessment in hospital laboratories, cardiopulmonary exercise testing in rehabilitation and sports medicine centers, and nutritional assessment in critical care units around the globe.”
The Ultima Series of products offers maximum flexibility to configure both pulmonary function and gas exchange systems to meet clinicians’ current and future diagnostic needs. The Ultima utilizes the latest technology and rapid response sensors for unparalleled performance and reliability. The features and capabilities of the Ultima Series meet the demands of the most exacting clinician.Dr. Justin Mortara, CEO of Mortara Instrument commented, “We’re excited to partner with Angeion. Just as Mortara Instrument is known worldwide for excellence in diagnostic ECG, MedGraphics is an internationally recognized leader in pulmonary systems. Combining their pulmonary technology with our VERITAS™ ECG algorithms and technology components brings two leaders together, resulting in an excellent solution for cardiopulmonary stress testing. Together, we’re helping clinical professionals at every level access essential information to non-invasively assess and successfully manage their patients’ care across the health continuum.”
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV